PREMIER: Rate of hypertension at 18 months

Slides:

Advertisements

Similar presentations

Efficacy and safety of angiotensin receptor blockers: a meta-analysis of randomized trials Elgendy IY et al. Am J Hypertens. 2014; doi:10,1093/ajh/hpu209.

Advertisements

(a) (b) (c) (d). What is (1,2,3)  (3,4,2)? (a) (1, 2, 3, 4) (b) (1,2)  (3,4) (c) (1,3,4,2) (d) (3,1)  (4,2)

* Plus–minus values are means ±SD. † Race was determined by the investigator. ‡ The body-mass index is the weight in kilograms divided by the square of.

The TRial Of Preventing HYpertension (TROPHY) TROPHY.

Pai JK et al. N Engl J Med 2004; 351: Relative CHD risk by increasing baseline CRP plasma levels,* relative to CRP

BluntPenetrating Placebo rFVIIa Patients (%) n=20 n=8 n=9 n=4 P=0.03 P=0.068 Adapted from Rizoli S. Canadian Anesthesiologists’

Solomon Tesfaye et al N Engl J Med 2005;352: Comparison of Baseline Data in 1819 Patients According to Whether There Was an Assessment for Neuropathy.

Implications of MDRD for Validity of Proteinuria as a Surrogate Endpoint.

Participant Characteristics by Lowest Leg AAI Category Ann M. O’Hare, et al, Circulation 2006;113;

Copyright © 2010 American Medical Association. All rights reserved.

LEADER trial: Primary Outcome

Baseline Demographic and Clinic Variables According to Office vs 24-Hour or Home BP Giuseppe Mancia, et al. Hypertension 2006;47;

CORAL Trial design: Patients with renal artery stenosis and hypertension or chronic kidney disease were randomized to renal artery stenting (n = 467) vs.

Flowchart of participants

SOCRATES Trial design: Patients with acute ischemic stroke were randomized in a 1:1 fashion to receive either ticagrelor 180 mg load + 90 mg BID or aspirin.

Baseline Characteristics of Women and Men in Whom Coronary Heart Disease Developed during Follow-up and Matched Controls - A Jennifer K. Pai et al. N.

(p < for group 1 or 2 vs. group 3)

CHOICE: Relative risk of death on peritoneal dialysis vs hemodialysis

Relative mortality risk associated with quartiles of systolic blood pressure compared with systolic

Nurses' Health Study: Risk of hypertension associated with >1000 µg/day of folate vs

NSAIDs: Risk of acute MI compared with remote use

End point Elevated PTH Normal PTH p % diameter stenosis < 0.05

Management of hypertension in patients with chronic kidney disease

Study Design Ketil Lunde, et al. N Engl J Med 2006;355:

Relative risk of major events with atenolol vs placebo

Outcome Relative risk with beta blockers 95% CI Stroke –1.30

Adjusted odds ratio for hypoglycemia with gatifloxacin and levofloxacin compared with macrolide antibiotics Antibiotic Odds ratio of hypoglycemia 95% CI.

End point Net change with soy supplements vs control (95% CI) p

Chapter 28 Nutrition, Lifestyle, and Hypertension

Primary end point in normotensive and hypertensive patients at baseline (events per 100 patient-years of follow-up) Primary end point Nifedipine Placebo.

Database-specific risk of ventricular arrhythmia associated with current use of azithromycin compared with current use of amoxicillin (2-stage random-effects.

Mancini JG, et al. Am J Cardiol.

VALUE: New-onset diabetes in an amlodipine-based vs valsartan-based therapy in high-risk hypertensives Diagnostic criteria Valsartan n (%) Amlodipine n.

Factors independently associated with odds of fractures

Relative risk reduction for incident hypertension associated with weight loss of 6.8 kg: The Framingham Study Cohort Risk reduction (%) Relative risk.

Forest plot of risk ratio with its 95% CI for the incidence of contrast-induced nephropathy among patient taking statin versus control based on renal impairment.

Life expectancy and baseline BP: Male participants

Cystatin C levels and risk of death from all causes

Risk for BMI outcome (%)

Baseline Characteristics of 400 Women Who Subsequently Developed Incident Hypertension (Case Subjects) and 400 Women Who Remained Free of Hypertension.

Adjusted relative risk for developing end-stage renal disease (ESRD) associated with blood-pressure level BP level (mm Hg) Adjusted relative risk 95%

Baseline Characteristics, Values at 24-Month Follow-up, and Changes from Baseline* - Part I John J.P. Kastelein, et al. N Engl J Med 2007;356: online.

Inclusion Criteria for Patients with Multiple Atherothrombotic Risk Factors and for Those with Established Cardiovascular Disease Deepak L.Bhatt, et al,

Patient characteristics: American vs Canadian transplant patients

Baseline Characteristics of the Subjects

Baseline Characteristics of the Patients and Use of Concomitant Medications – Part I Kaare Harald Bønaa, et al. N Engl J Med 2006;354:

A.V. Khera et al. N Engl J Med 2011;364:127-35

DENERHTN Trial design: Patients with resistant hypertension were randomized to renal denervation plus standardized stepped-care antihypertensive treatment.

Patient Disposition James A. de Lemos et al. JAMA 2004; 292:

Baseline Characteristics of Study Populations

DANAMI 3-DEFER Trial design: Patients presenting with STEMI and in whom the operators could establish TIMI 2-3 flow without stenting or those presenting.

Entry, Randomization, and Follow-up of Patients in the Hypertension in the Very Elderly Trial Of the 461 patients who did not meet the protocol criteria,

Baseline Characteristics of the Patients – Part I

Long-term risk for ever being overweight or more or obese

EMPA-REG OUTCOME: Cumulative incidence of the primary outcome

Mean (95% CI) fasting s-glucose at baseline and 6-month, 12-month, and 24-month follow-up, overall and by sex (A), and by baseline age (B), education (C),

Absolute mortality difference Change in LVEF from baseline

Mean pulmonary arterial systolic pressure (PASP) with 95% CI error bars and individual data points at rest breathing room air (baseline), during 20 min.

Meta-analysis of risk ratios for percentage of patients who developed catheter-associated urinary tract infection, for intervention versus control groups,

Flowchart of the process of study selection LAR indicates laboratory-defined aspirin resistance Jaapjan D. Snoep, et al. Arch Intern Med 2007;167:

Increase of physical activity over time associated with lower HF risk

Meta-analysis of risk ratios for percentage of patients who developed catheter-associated urinary tract infection, for intervention versus control groups,

Characteristics of 3415 patients admitted to hospital with

The percentage of patients in the baseline audit that had each measure of the antipsychotic monitoring over the previous 12 months. The percentage of patients.

Baseline New York Heart Association functional class (NYHA FC) predicts survival in patients with pulmonary hypertension using infused epoprostenol therapy.

Optimizing therapy for nodal marginal zone lymphoma

Mean with 95% CI error bars and individual data points of right ventricular function parameters at rest breathing room air (baseline), during 20 min breathing.

The cumulative incidence curve demonstrated that patients with a sub-optimal LDL-C response to statin therapy were associated with a higher risk of CVD.

Average change in blood pressure (BP) from recruitment to 6-month postrecruitment in intervention and control patients >50 years included due to having.

Presentation transcript:

PREMIER: Rate of hypertension at 18 months End point Baseline Advice only Established recommendations Established recommendations plus DASH diet Patients with hypertension (%) 37 32 24 22 Elmer PJ et al. Ann Intern Med 2006; 144:485-495.

Risk of hypertension with established recommendations and established recommendations plus DASH diet vs advice only at 18 months Group Odds ratio 95% CI Established recommendations 0.83 0.67-1.04 Established recommendations plus DASH diet 0.77 0.62-0.97 Elmer PJ et al. Ann Intern Med 2006; 144:485-495.